Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Exchange Rate Effect (2018 - 2020)

Serina Therapeutics' Exchange Rate Effect history spans 3 years, with the latest figure at -$2000.0 for Q4 2020.

  • For Q4 2020, Exchange Rate Effect fell 166.67% year-over-year to -$2000.0; the TTM value through Dec 2020 reached $1000.0, down 85.71%, while the annual FY2020 figure was $1000.0, 0.0% changed from the prior year.
  • Exchange Rate Effect for Q4 2020 was -$2000.0 at Serina Therapeutics, roughly flat from -$2000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $8000.0 in Q2 2018 and bottomed at -$3000.0 in Q3 2019.
  • The 3-year median for Exchange Rate Effect is -$1000.0 (2018), against an average of $777.78.
  • The largest annual shift saw Exchange Rate Effect plummeted 200.0% in 2019 before it skyrocketed 33.33% in 2020.
  • A 3-year view of Exchange Rate Effect shows it stood at -$1000.0 in 2018, then surged by 400.0% to $3000.0 in 2019, then crashed by 166.67% to -$2000.0 in 2020.
  • Per Business Quant, the three most recent readings for SER's Exchange Rate Effect are -$2000.0 (Q4 2020), -$2000.0 (Q3 2020), and $6000.0 (Q2 2020).